News & Updates

Conversion from robotic partial to radical nephrectomy is low among patients with a renal mass, while that due to uncontrolled bleeding is even lower, according to a study.

Intravesical interferon instillation appears to benefit women with interstitial cystitis (IC), with a recent study showing that the approach helps improve patient-reported and objective outcomes compared with hyaluronic acid without serious adverse events.

Researchers have developed an artificial intelligence (AI)-enabled tool that can automatically detect vital steps during robotic-assisted radical prostatectomy (RARP) with high accuracy.

Over 150 million men suffer from erectile dysfunction (ED) worldwide.^1,2 Despite its growing incidence, it remains underdiagnosed, with millions of men never seeking medical attention because of the sensitivity of the issue.²

New drug applications approved by US FDA as of 1-15 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

An intervention using an electronic mobile health (mHealth) tool is not only feasible and acceptable but also delivers useful educational content and symptom management to patients undergoing radical cystectomy, according to a study.

Adherence to thiazide diuretics among patients with urolithiasis and hypercalciuria leads to fewer symptomatic stone events, as does adherence to alkali therapy among those with low urine pH, according to a retrospective cohort study.